Coronaviruses are positive-strand RNA viruses that cause respiratory infections in humans and important gastrointestinal and neurologic disease in other animal species. Mouse hepatitis virus (MHV) is a model for studies of coronavirus replication and pathogenesis. The central goal of the proposed research is to define interactions of mouse hepatitis virus with host cells during formation and function of viral replication complexes. MHV directs viral RNA synthesis on membranous replication complexes that are distributed thoughout the cytoplasm. These complexes are distinct from sites of virion assembly in the intermediate compartment of the Golgi (ERGIC). Proteins processed from the replicase gene polyprotein localize with the nucleocapsid (N) protein at sites of viral RNA synthesis in two closely associated protein complexes, the p22/p65 complex and the hel/N complex. At late times of infection, the hel/N complexes separate from the p22/p65 complexes and translocate to sites of virion assembly in the ERGIC. However, the precise composition of replication complexes is not known, and the mechanism of hel/N complex translocation has not been determined. This proposal describes an integrated research program to define the organization and translocation of MHV replication complexes.
In Specific Aim 1, the protein and membrane composition of MHV replication complexes will be determined.
In Specific Aim 2, the mechanism of hel/N complex translocation to the ERGIC will be defined.
In Specific Aim 3, the functions of viral proteins in replication complex translocation will be determined. These studies will identify fundamental mechanisms by which MHV directs replication complex formation and function and will define virus-cell interactions that are essential for successful virus replication.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI050083-01A2
Application #
6574566
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Park, Eun-Chung
Project Start
2002-12-15
Project End
2007-11-30
Budget Start
2002-12-15
Budget End
2003-11-30
Support Year
1
Fiscal Year
2003
Total Cost
$344,189
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Beachboard, Dia C; Anderson-Daniels, Jordan M; Denison, Mark R (2015) Mutations across murine hepatitis virus nsp4 alter virus fitness and membrane modifications. J Virol 89:2080-9
Freeman, Megan Culler; Peek, Christopher T; Becker, Michelle M et al. (2014) Coronaviruses induce entry-independent, continuous macropinocytosis. MBio 5:e01340-14
Freeman, Megan Culler; Graham, Rachel L; Lu, Xiaotao et al. (2014) Coronavirus replicase-reporter fusions provide quantitative analysis of replication and replication complex formation. J Virol 88:5319-27
Beachboard, Dia C; Lu, Xiaotao; Baker, Susan C et al. (2013) Murine hepatitis virus nsp4 N258T mutants are not temperature-sensitive. Virology 435:210-3
Gadlage, Mark J; Sparks, Jennifer S; Beachboard, Dia C et al. (2010) Murine hepatitis virus nonstructural protein 4 regulates virus-induced membrane modifications and replication complex function. J Virol 84:280-90
Graham, Rachel L; Sparks, Jennifer S; Eckerle, Lance D et al. (2008) SARS coronavirus replicase proteins in pathogenesis. Virus Res 133:88-100
Sparks, Jennifer S; Donaldson, Eric F; Lu, Xiaotao et al. (2008) A novel mutation in murine hepatitis virus nsp5, the viral 3C-like proteinase, causes temperature-sensitive defects in viral growth and protein processing. J Virol 82:5999-6008
Zhao, Zijiang; Thackray, Larissa B; Miller, Brian C et al. (2007) Coronavirus replication does not require the autophagy gene ATG5. Autophagy 3:581-5
Sparks, Jennifer S; Lu, Xiaotao; Denison, Mark R (2007) Genetic analysis of Murine hepatitis virus nsp4 in virus replication. J Virol 81:12554-63
Denison, Mark R (2004) Severe acute respiratory syndrome coronavirus pathogenesis, disease and vaccines: an update. Pediatr Infect Dis J 23:S207-14

Showing the most recent 10 out of 13 publications